510(k) Report

510(k) · Cleared

Cleared

Neuro Wave 6

K062003510(k) TraditionalCleared Sep 19, 2007429-day reviewClass II21 CFR 882.5890

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Lhasa Oms, Inc. · GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

Cleared on Sep 19, 2007 as substantially equivalent to K051020 (Lhasa Oms, Inc., 2006) after a 429-day review. Its family tree reaches back 2 generations to 1991. 3 later devices descend from it.

Decided
Sep 19, 2007
Review
429 days
Class
Class II
Product code
GZJ
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K904388 (1991). 3 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2009: 1 descendant cleared2015: 1 descendant cleared2020: 1 descendant clearedK904388 · Pointer F-3 Tens · Oms Medical Supplies, Inc. · 1991K051020 · ES-160 · Lhasa Oms, Inc. · 20061990200020102020
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 1 descendant3 generations forward: 1 descendant K051020 · ES-160 · Lhasa Oms, Inc. · 2006K904388 · Pointer F-3 Tens · Oms Medical Supplies, Inc. · 19910
  1. Root · 2 generations backK904388 Pointer F-3 TensOms Medical Supplies, Inc. · 1991
  2. 1 generation backK051020 ES-160Lhasa Oms, Inc. · 2006
  3. This deviceK062003 Neuro Wave 6Lhasa Oms, Inc. · 2007
  4. Descendant · cites it directly · 2 of its ownK081255 Scrambler ST 5 Tens DeviceCompetitive Technologies,Inc. · 2009
  5. Descendant · 2 generations on · 1 of its ownK142666 Scrambler Therapy MC-5 A DeviceDelta International Services & Logistics S.R.L · 2015
  6. Descendant · 3 generations on · 0 of its ownK201458 Scrambler Therapy Technology (Model ST-5A)Delta International Services & Logistics S.R.L · 2020

Most influential descendants

Showing 3 of 3 · See all
  • K081255Scrambler ST 5 Tens DeviceCompetitive Technologies,Inc. · 2009 · cites it directly2descendants
  • K142666Scrambler Therapy MC-5 A DeviceDelta International Services & Logistics S.R.L · 2015 · 2 generations on1descendant
  • K201458Scrambler Therapy Technology (Model ST-5A)Delta International Services & Logistics S.R.L · 2020 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K904388Pointer F-3 TensOms Medical Supplies, Inc.1991—
−1K051020ES-160Lhasa Oms, Inc.2006—
0 (this device)K062003Neuro Wave 6Lhasa Oms, Inc.2007—
+1K081255Scrambler ST 5 Tens DeviceCompetitive Technologies,Inc.2009—
+2K142666Scrambler Therapy MC-5 A DeviceDelta International Services & Logistics S.R.L2015—
+3K201458Scrambler Therapy Technology (Model ST-5A)Delta International Services & Logistics S.R.L2020—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200910
201510
202010
FIG. 1 — Lineage of K062003, 1991–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GZJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GZJ device

  1. #1 K252767 actiTENS miniscore 13.1 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K051020ES-160
Summary page 1
…aneous electrical nerve stimulator, Class II,21 CFR 882.5890. Legally marketed device for substantial equivalence comparison: ES-160, K051020 Description of the device: The device consists of a battery powered portable instrument with 6 channel outputs. Weight- 2.6 kg.…
Lhasa Oms, Inc.2006—

Also cleared against K051020: 2 other devices →

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K081255Scrambler ST 5 Tens DeviceCompetitive Technologies,Inc.20092

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 16 years and passes through 2 companies; a new generation was cleared every 14.7 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K081255 (Competitive Technologies,Inc., 2009) has gone furthest, with 2 descendants of its own.
  • 2 other devices also cite its predicate K051020.

How does its category compare?

All GZJ devices

GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · GZJ

1in 2025

2007: 132008: 112009: 162010: 52011: 52012: 122013: 22014: 42015: 32016: 32017: 32018: 22019: 32020: 42021: 32022: 42023: 12024: 32025: 12026 (partial year): 2
2007high 16 (2009) · low 1 (2023)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GZJ

207in 2024

2007: 223 days median2008: 136 days median2009: 155 days median2010: 232 days median2011: 168 days median2012: 154 days median2014: 344 days median2015: 202 days median2016: 163 days median2017: 113 days median2019: 156 days median2020: 183 days median2021: 231 days median2022: 175 days median2024: 207 days median
2007high 344 (2014) · low 113 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GZJ

1in 2011

2007: 42008: 12011: 1
2007high 4 (2007) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GZJ

13in 2025

2007: 42008: 452009: 172010: 222011: 222012: 202013: 102014: 232015: 182016: 322017: 582018: 212019: 72020: 102021: 52022: 42023: 392024: 122025: 13
2007high 58 (2017) · low 4 (2007)2025

MAUDE reports naming product code GZJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071322344
200811136145
200916155017
20105232022
20115168122
201212154020
20132—010
20144344023
20153202018
20163163032
20173113058
20182—021
2019315607
20204183010
2021323105
2022417504
20231—039
20243207012
20251—013
20262—0—

What is it indicated for?

The Neuro Wave 6 is intended for use in the symptomatic relief of chronic intractable pain, postoperative pain, and acute pain.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K062003: Neuro Wave 6.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K062003

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026